Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis

European Journal of Clinical Investigation ◽

10.1111/j.1365-2362.1992.tb01495.x ◽

1992 ◽

Vol 22 (7) ◽

pp. 488-493 ◽

Author(s):

G. VREUGDENHIL ◽

B. LÖWENBERG ◽

H. G. VAN EIJK ◽

A. J. G. SWAAK

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Disease Activity ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response

Drug Development Research ◽

10.1002/ddr.21203 ◽

2014 ◽

Vol 75 ◽

pp. S77-S80 ◽

Author(s):

Fabio Cacciapaglia ◽

Maria Grazia Anelli ◽

Angela Rinaldi ◽

Lucia Serafino ◽

Michele Covelli ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Disease Activity ◽

Lipid Profile ◽

Clinical Response ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

MicroRNA 146a Expression in Rheumatoid Arthritis: Association with Tumor Necrosis Factor–Alpha and Disease Activity

Genetic Testing and Molecular Biomarkers ◽

10.1089/gtmb.2011.0026 ◽

2011 ◽

Vol 15 (11) ◽

pp. 807-812 ◽

Author(s):

Abla Abou-Zeid ◽

Mowaffak Saad ◽

Eiman Soliman

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Disease Activity ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

ClinicoEconomics and Outcomes Research ◽

10.2147/ceor.s136327 ◽

2017 ◽

Vol Volume 9 ◽

pp. 451-458 ◽

Author(s):

Daniel Aletaha ◽

Sonya Snedecor ◽

Varun Ektare ◽

Mei Xue ◽

Yanjun Bao ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Economic Analysis ◽

Disease Activity ◽

Tumor Necrosis Factor Alpha ◽

Stable Disease ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Serum Tumor Necrosis Factor-Alpha as a Competent Biomarker for Evaluation of Disease Activity in Early Rheumatoid Arthritis

Cureus ◽

10.7759/cureus.15314 ◽

2021 ◽

Author(s):

Mehreen Inam illahi ◽

Sofia Amjad ◽

Syed Mehfooz Alam ◽

Syed Tousif Ahmed ◽

Murk Fatima ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Disease Activity ◽

Tumor Necrosis Factor Alpha ◽

Early Rheumatoid Arthritis ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor ◽

Serum Tumor Necrosis

Download Full-text

Faculty Opinions recommendation of Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166921.629011 ◽

2009 ◽

Author(s):

Will Dixon

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Cancer Risk ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718203203.793488248 ◽

2013 ◽

Author(s):

Ali Mobasheri

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Synovial Fluid ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Rheumatoid Arthritis Synovial Fluid ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Six-transmembrane epithelial antigen of prostate4 (STEAP4) is a tumor necrosis factor alpha-induced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis

Modern Rheumatology ◽

10.3109/s10165-011-0475-y ◽

2012 ◽

Vol 22 (1) ◽

pp. 128-136 ◽

Author(s):

Yoko Tanaka ◽

Isao Matsumoto ◽

Keiichi Iwanami ◽

Asuka Inoue ◽

Reiko Minami ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cell Proliferation ◽

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Engineered Human Anti-Tumor Necrosis Factor-Alpha (TNFα) Antibody, CDP571, in Rheumatoid Arthritis

Novel Therapeutic Agents for the Treatment of Autoimmune Diseases ◽

10.1201/9781482273533-21 ◽

1996 ◽

pp. 143-152

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Relation Between Disease Activation, and Serum Erythrocyte Sediment Level and C-reactive Protein Levels in Rheumatoid Arthritis Patients Receiving Anti Tumor Necrosis Factor Alpha Treatment

Eurasian Journal of Medicine and Oncology ◽

10.14744/ejmo.2017.47955 ◽

2017 ◽

Author(s):

Gülçin Güngör Olçum

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

C Reactive Protein ◽

Necrosis Factor Alpha ◽

Protein Levels ◽

Reactive Protein ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction

Journal of Traditional Chinese Medicine ◽

10.1016/s0254-6272(16)30082-6 ◽

2016 ◽

Vol 36 (5) ◽

pp. 625-633 ◽

Author(s):

Liu Defang ◽

Yan Jiao ◽

Yun Mingdong ◽

Yang Ming ◽

Luo Yong ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Synovial Fluid ◽

Tumor Necrosis Factor Alpha ◽

Interferon Gamma ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Symptom Pattern ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text